A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial. The drug, rimegepant, is awaiting US Food and Drug Administration approval and may offer advantages over currently available migraine medications.
Click here for original story, Novel therapy for acute migraine shows promise in phase 3 clinical trial
Source: ScienceDaily